Drug class

Antineoplastic - Immunotherapy, Therapeutic Vaccines

The phrase "Antineoplastic - Immunotherapy, Therapeutic Vaccines" is an administrative and formulary classification used by compendia and payer formularies to categorize active immunotherapies designed to treat existing malignancies rather than prevent infection. Read more about Antineoplastic - Immunotherapy, Therapeutic Vaccines

1 drugs in this class 1 manufacturers

Advertisement

Drugs in Antineoplastic - Immunotherapy, Therapeutic Vaccines

Showing 1–1 of 1 drugs

Filter & compare in the drug finder → Opens the drug finder with Antineoplastic - Immunotherapy, Therapeutic Vaccines preselected. Add indication or manufacturer filters there.

About Antineoplastic - Immunotherapy, Therapeutic Vaccines.

The phrase "Antineoplastic - Immunotherapy, Therapeutic Vaccines" is an administrative and formulary classification used by compendia and payer formularies to categorize active immunotherapies designed to treat existing malignancies rather than prevent infection.

Agents in this class work by exposing antigen-presenting cells to tumor-associated antigens or neoantigens, stimulating a targeted, systemic host immune response characterized by the proliferation of cytotoxic T lymphocytes directed against tumor cells.

The primary clinical example is autologous cellular immunotherapy, such as sipuleucel-T, indicated for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.

Research across oncology also actively investigates therapeutic cancer vaccines in modalities spanning peptide, dendritic cell, and nucleic acid platforms for advanced solid tumors and recurrent hematologic diseases.